Establishment of a regenerative medicine to accelerate the re-epithelialization in acute or chronic wounds by means of a microskin grafting and administration of Fiblast Spray (bFGF)
Not Applicable
- Conditions
- Acute wounds:burns, donor site wounds Chronic wounds:pressure ulcers
- Registration Number
- JPRN-UMIN000006418
- Lead Sponsor
- Miyoko Kubo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have complications of 1) Malignancy, 2) Severe systemic illness affecting the liver, kidney, lung, heart, blood, brain and neurological systems
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Speed of the re-epithelialization (days until completion of the re-epithelialization) 2. Appearance, quality (thickness, viscoelasticity) and contraction rate of the healed skin after completion of the re-epithelialization 3. Histological findings
- Secondary Outcome Measures
Name Time Method